Patients with Type II Diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Placebo group 3): receiving placebo capsules, daily before lunch + anti-diabetic medication, for 45 days
Intervention 1: Placebo group 3): receiving placebo capsules, daily before lunch + anti-diabetic medication, for 45 days. Intervention 2: Intervention group 2): receiving 500 mg capsules containing Do
Placebo
Treatment - Drugs
Intervention group 2): receiving 500 mg capsules containing Dorema aucheri (DA) powder, daily before lunch + anti-diabetic medication, for 45 days
Intervention group 1): receiving 100 mg capsules containing Dorema aucheri (DA) powder, daily before lunch + anti-diabetic medication, for 45 days
Sponsors
Shahid Sadoughi University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: a minimum of 2-year experience with type II diabetes diagnosed by a physician endocrinologist; 40-65 years of age, Exclusion criteria: free of dietary restrictions/food allergies; not receiving insulin therapy; not using medications or supplementation known to alter sugar/lipid metabolism; no clinical history of cardiovascular, hepatic, gastrointestinal, or renal disease; no recent history of smoking.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood levels of glucose. Timepoint: At the baseline of experiment and after 45 days at the end of experiment. Method of measurement: Blood testing. | — |
Secondary
| Measure | Time frame |
|---|---|
| The blood level of cholesterol. Timepoint: At the baseline of experiment and after 45 days at the end of experiment. Method of measurement: Blood testing. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Pourrajab
Shahid Sadoughi University of Medical Sciences
Outcome results
None listed